This effect, as well as the one observed due to REO + ICB combination therapy, was observed only in the presence of reovirus since the proinflammatory stimuli were necessary to drive the expression of FcγR-expressing, or PD-1-expressing, effector cells in the tumor. The gene discussed is FCGR2A; the disease is neoplasm.